{
  "paper_metadata": {
    "pmid": "30972954",
    "title": "Comprehensive analysis of serum tumor markers and BRCA1/2 germline mutations in Chinese ovarian cancer patients",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from ovarian cancer patients."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3109C>T",
      "protein_notation": "p.Arg1037Cys",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 16,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 16,
        "affected_count": 16,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P11",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P12",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P13",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P14",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P15",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P16",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        }
      ],
      "functional_data": {
        "summary": "The mutations in BRCA2 are associated with a high risk of ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study identified multiple mutations in BRCA2.",
      "key_quotes": [
        "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3598_3599delTG",
      "protein_notation": "p.Leu1200fs",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 16,
        "demographics": "not specified",
        "phenotype": "ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 16,
        "affected_count": 16,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P10",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P11",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P12",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P13",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P14",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P15",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        },
        {
          "individual_id": "P16",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ovarian cancer",
          "evidence_sentence": "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
        }
      ],
      "functional_data": {
        "summary": "The mutations in BRCA2 are associated with a high risk of ovarian cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study identified multiple mutations in BRCA2.",
      "key_quotes": [
        "For BRCA2, 13 deleterious germline mutations were found in 16 (6.9%) patients."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 3",
      "table_caption": "Deleterious germline mutations of BRCA1/2 found in 232 ovarian cancer patients",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}